HarborPath began administering The ADAP Waiting List program on May 6, 2013. Case managers, on behalf of their patients, wishing to access the HarborPath ADAP Waiting List Program should complete and certify a HarborPath ADAP Waiting List Program Enrollment Form (form downloadable from sidebar), include new prescriptions, and submit to HarborPath for the dispensing of available medications.
A patient is eligible for the HarborPath ADAP Waiting List Program if he or she meets the following criteria:
No other ADAP patients are eligible for this program (e.g. patients who have enrolled with an ADAP but whose eligibility has not yet been determined). Individual pharmaceutical companies’ PAP business rules are not applied to patients in the HarborPath ADAP Waiting List Program.
In order to streamline access to medications for patients who are on ADAP waiting lists, participating drug companies have agreed to a simplified eligibility process. Rather than completing individual company patient assistance program (PAP) applications, patients on ADAP waiting lists are qualified using a simple HarborPath ADAP Waiting List Program Enrollment Form (form downloadable from sidebar).
Following are the steps to be completed to enroll a patient in the HarborPath ADAP Waiting List program:
Once a complete HarborPath ADAP Waiting List Program Enrollment Form and prescriptions are received by HarborPath, applications will be processed and medications will be shipped via U.S. Postal Service within 48 hours of receipt of the application.
The AIDS Drug Assistance Program (ADAP) is part of the Federal Ryan White Part B program that is administered through the Health Resources and Services Administration (HRSA) at the Department of Health and Human Services. ADAP funding is made available annually to all 50 states and is to be used to provide medications to people living with HIV/AIDS who have no other payer source such as Medicaid, Medicare or private insurance. ADAP funding may also be used to pay for insurance premiums, copays and deductibles for people living with HIV/AIDS.
Despite appropriations increases, the steady growth in the number of eligible clients, combined with rising costs of complex HIV/AIDS treatments, sometimes results in states experiencing greater demand for ADAP services than available resources can cover. In these instances, some ADAPs have implemented waiting lists for program services and medications.
Through the ADAP Waiting List Program, antiretrovirals donated by pharmaceutical companies are dispensed to patients who are on ADAP Waiting Lists. The program that began in 2010 is now being administered by HarborPath. The primary focus of HarborPath is to serve people living with HIV who are uninsured, ineligible for ADAPs and/or are experiencing a gap in coverage for their HIV medications. Administering the ADAP Waiting List Program is directly aligned with its core mission.